A company based in the Finland that makes alternative energy and materials has unveiled a variety of bioinks. The bioink is called GrowInk and it is created for different additive manufacturing applications like regenerative medicine and tissue engineering.
The GrowInk variety features unique non-animal obtained hydrogels. They follow the in vivo setting to promote the differentiation and growth of cell. The materials premiered at the SLAS2020 science convention in San Diego.
UPM was started in 1996. It creates and distributes maintainable wood-based biomedical commodities. The GrowDex line of UPM consists of hydrogels for 3D cell research and culturing. In 2018, the firm unveiled a recyclable biocomposite thread of FDM 3D printing machines. It also unveiled UPM Formi 3D that utilizes biopolymers and cellulose fibers.
The past year, the biotechnology firm and it’s branch UPM Biocomposites and also robotics maker ABB and Prenta Oy got into a partnership. The aim was to make huge pieces and furniture by the use of its reusable UPM Formi fiber.
As stated by UPM, the two key pieces of its bioinks, GrowInk include water and its nanofibrillar cellulose. This is combined to offer a specified matrix that may be instantly combined with cells and tailored. A septic hydrogel called GrowDex-A has as well been included. This hydrogel is intended to connect biotinylated molecules. This includes peptides, proteins, and medicines for 3D cell culture.
Presently, the growing materials are present in three distinctions. The initial, GrowInk-N is a simple concealed bioink created of real nanofibrillar cellulose. GrowInk-T is a clear, anionic nanofibrillar cellulose bioink for enhanced processes that may be unessentially cross-connected to strengthen printed compositions. Eventually, GrowInk-ALG a nanofibrillar cellulose-based bioink with alginate that can be cross-connected.
GrowInk Bioinks offers exceptional imaging quality. They are ideal for several and various 3D bioprinting purposes. They include cell encapsulation and scaffold preparing for drug study.